Craig D Wegner

Title: Craig D Wegner: Innovator in Asthma Treatment

Introduction

Craig D Wegner is a notable inventor based in New Milford, CT (US). He has made significant contributions to the field of medicine, particularly in the treatment of asthma. With a total of 3 patents to his name, Wegner's work focuses on innovative methods to alleviate the symptoms of this chronic condition.

Latest Patents

Wegner's latest patents include groundbreaking inventions related to intercellular adhesion molecules. One of his notable patents discusses the use of intercellular adhesion molecule-1 (ICAM-1) and its fragments, along with anti-CD18 antibodies, in treating asthma. This invention highlights the potential of these molecules in reducing the severity of asthma attacks. Another patent emphasizes the use of antibodies to ICAM-1, providing a method to decrease the hyperresponsive reactions associated with asthma.

Career Highlights

Craig D Wegner is currently associated with Boehringer Ingelheim Pharmaceuticals, Inc., where he continues to advance his research and innovations. His work has been instrumental in developing new therapeutic approaches for asthma, showcasing his commitment to improving patient outcomes.

Collaborations

Wegner has collaborated with esteemed colleagues, including Robert H Gundel and Robert Rothlein. These partnerships have further enriched his research and contributed to the success of his inventions.

Conclusion

Craig D Wegner's contributions to asthma treatment through his innovative patents demonstrate his dedication to medical advancements. His work continues to inspire and pave the way for future research in this critical area of health.